Nutra BioGenesis is Drug Discovery in United States that focus on metabolic health business. Founded in 2000. They cover business area such as manufacturer, nutraceutical drug product, nutraceutical product, inflammation, pain, foundational nutrition, detoxification, intestinal health, weight loss, mental wellness, cardiovascular support, metabolic health, its product, UltraLean Body Composition, BioCleanse.
2000
( 24 years old in 2024 )
Metabolic Health
-
18303 Bothell-Everett Highway
Suite 110
Mill Creek, WA 98012
United States
Private
manufacturernutraceutical drug productnutraceutical productinflammationpainfoundational nutritiondetoxificationintestinal healthweight lossmental wellnesscardiovascular supportmetabolic healthits productUltraLean Body CompositionBioCleanse
* We use standard office opening hours in near Nutra BioGenesis's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Nutra BioGenesis is Drug Discovery business from United States that founded in 2000 (24 years old in 2024), Nutra BioGenesis business is focusing on Metabolic Health.
Nutra BioGenesis headquarter office and corporate office address is located in 18303 Bothell-Everett Highway Suite 110 Mill Creek, WA 98012 United States.
Nutra BioGenesis was founded in United States.
In 2024, Nutra BioGenesis is currently focus on metabolic health sector.
Above is snippet of Google Trends for "metabolic health" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Nutra BioGenesis, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
